Sanger sequencing and real-time PCR methods have been the standard molecular methods in clinical diagnostics for decades. Deep sequencing or Next Generation Sequencing (NGS) technology revolutionized ...
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) has provided new insights into its next-generation sequencing (NGS) initiative, unveiling an innovative sample-to-result NGS workflow designed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback